# 1. Financial Performance ## A. Key Figures * **Operating Revenue:** **₹940 Cr** (+8.4% YoY, +2.8% QoQ) (0.2% constant currency) * Operational EBITDA: ₹145.5 Cr (+1.7% YoY, +6% QoQ) · EBITDA Margin: 15.5% (+50 bps) * Net Profit: ₹97.4 Cr (+6% QoQ, -24% YoY) · Normalized Net Profit Growth: +14% YoY * **DSO:** **80 days** (Q1 FY26) (-2 days QoQ, -15 days YoY) ## B. Revenue Growth * **One-Off Revenue Tailwind:** Recognition of **~$5 million** in future quarter to support top-line, though timing remains unconfirmed. * **Productivity-Driven Leverage:** Revenue per resource on upward trajectory, supported by AI-enabled efficiency gains and selective attrition management. ## C. Profitability Trends * **Margin Expansion Underway:** EBITDA margin improved 50 bps, driven primarily by **operational efficiencies** with minor FX tailwind (~10 bps). * **Geographic Margin Divergence:** U.K. margins improving in line with growth; U.S. and Middle East still below target levels. * **Profit Quality Strengthening:** Normalized net profit grew double-digits YoY, despite prior-year comparison burdened by exceptional gain. ## D. Cash Flow Health * **Working Capital Discipline Intact:** DSO reduction to 80 days reflects sustained improvement, particularly in AMEA region. * **Efficiency Over Layoffs:** No active headcount reduction; instead, managed attrition without full backfilling is boosting resource productivity. --- # 2. Order Book & Backlog ## A. Key Figures * **Contract Mix:** **40%** fixed price · **60%** time and material (T&M) ## B. 12-Month Backlog * **Backlog Pressure:** 12-month order book growth suppressed by client shift toward **shorter-term contracts** (1-year, 6-month, quarterly) versus traditional 3- to 5-year deals. * **Efficiency Gains:** Internal operational efficiency initiatives are yielding **cost-effective service delivery** and **G&A optimization**, with tangible bottom-line benefits emerging. * **Strategic Execution:** Data modernization platform rollout now in execution phase under a defined **three-year implementation plan**. * **North America Outlook:** Despite near-term backlog softness, **higher ACVs** on new contracts are expected to drive improvement in order book to revenue ratio. ## C. Contract Duration Trends * **Regional Divergence:** North America faces **shorter durations** and delayed decisions, while U.K. and Europe maintain **long-term 3- to 5-year contracts**, especially in government and key verticals. ## D. Regional Backlog Mix * **Geographic Skew:** Current order book is **disproportionately weighted toward U.K. and Europe**, highlighting regional imbalance in recent booking momentum. --- # 3. Segment & Geography Performance ## A. Key Figures * **Deal Value:** **$15M+** U.K. private sector AI-led deal · **$7M+** APAC & Middle East healthcare deal · **$5M+** AMEA AI transformation deal ## B. U.K. & Europe * **Core Growth Engine:** U.K. remains Mastek’s largest and most resilient market, with strong performance across healthcare, government, and private sector despite near-term growth softness. * **Government & NHS Resilience:** Secured Government Services shows robust renewal activity with 3- to 5-year visibility; operations across NHS departments remain unaffected by competitor contracts. * **Private Sector Momentum:** AI-driven demand fuels new client wins and share gains, highlighted by a **$15M+ modernization deal** with a major financial services firm. * **Strategic Positioning:** Leadership engagement with U.K. government underscores deep trust and long-term positioning in public sector digital transformation. ## C. North America * **Leadership-Led Turnaround:** Appointment of Sourabh Mukherjee signals renewed focus on growth, particularly in healthcare and life sciences. * **Growth Verticals & Headwinds:** Strategic emphasis on healthcare, Oracle, Salesforce, and data services continues, though macro pressures are causing a right shift in demand. * **Data & AI Reboot:** Data and AI growth lags expectations, but new leadership is launching targeted modernization campaigns to reaccelerate momentum. ## D. APAC & Middle East * **Focused Expansion:** Strategy emphasizes consolidation and targeted growth in healthcare, supported by a **$7M+ regional deal** and a new **$5M+ AI-led transformation contract**. * **Profitability Tailwinds:** DSO improvement and profitability gains on track; a one-off **unrecognized WAR revenue** event due to documentation delay will boost future regional margins. * **Conservative Revenue Policy:** Revenue recognized only upon full documentation, ensuring high-quality, audit-compliant financial reporting despite delivery progress. --- # 4. AI & Technology Initiatives ## A. Key Figures * **Data & AI Business Growth:** **25%–30%** QoQ (prior trend) ## B. AI for Tech * **Dual Efficiency Gains:** AI for tech is driving measurable improvements in both customer and internal operational efficiency, supporting a steady trajectory of bottom-line improvement. * **Strategic Recognition:** Company named an Oracle AI for supply chain partner, reinforcing leadership in AI integration within Oracle ecosystems. * **High-Impact Implementation:** Leading Bank of England’s core data modernization on Databricks, establishing strategic footprint in public sector AI infrastructure. ## C. AI for Business * **Next-Wave Transformation:** AI for tech is evolving into AI for business, with **nearly a dozen clients** engaged on transformation roadmaps ahead of expected FY '27 execution, signaling a major shift in client adoption. * **Self-Validation Strategy:** Internal AI-driven efficiencies—evidenced by head count reductions—are being demonstrated to build client trust and secure roles in large-scale business transformations. * **Reinvestment for Scale:** Efficiency savings are being channeled into building new capabilities in **Agentic AI** and AI-led business transformation solutions. * **Value Sharing Model:** A portion of AI-driven gains is being passed to clients to demonstrate tangible benefits and strengthen commercial positioning. ## D. Oracle Partnership * **Strategic Differentiation:** Mastek’s deep alignment with Oracle—especially in **Oracle Health**—positions it as a key partner in cloud migration and managed services within a high-growth vertical. * **Infrastructure Advantage:** Oracle’s accelerated GPU delivery and cloud investments create tailwinds for Mastek, enhancing competitiveness in AI infrastructure deployment. * **Exclusive Positioning:** Among the few global partners actively engaged in Oracle Health cloud and managed services, enabling expansion beyond traditional healthcare IT roles. --- # 5. Client & Demand Trends ## A. Key Figures * **Deal Value:** **GBP 5 Cr+** AI-led engineering services deal secured in government services ## B. Vertical Demand * **Sustained U.K. Healthcare Momentum:** Strong demand continues, underpinned by government policy and fiscal support, with AI-driven modernization accelerating project execution. ## B. Client Contracting * **Shift Toward Outcome-Based Models:** AI-driven productivity is accelerating adoption of **fixed-price and outcome-based pricing**, with T&M contracts evolving into **T&M with efficiency-sharing** or outcome focus. * **Commercial Models Still Evolving:** Pricing frameworks for AI services remain fluid, as clients and providers experiment with hybrid structures to align incentives. ## C. Deal Conversion * **Proven Model for Scaling Deals:** Secured long-term government relationships enable renewal and expansion, with recent success in winning **large AI-led modernization deals** via demonstrated internal value. --- # 6. Execution & Operational Risks ## A. Leadership & Execution Focus * **Regional Leadership Stabilized:** Restructuring in North America completed, including appointment of a **new head for the Salesforce business**, capping a **5-quarter leadership overhaul** aimed at strengthening regional performance. * **Operational Discipline Prioritized:** Emphasis on **technical execution** across engineering, Oracle, and Salesforce units to enhance cost efficiency and service delivery. * **High-Stakes Data Precision:** Execution risk centers on **consolidating high-volume banking data** from multiple sources, demanding near-zero error rates in data strategy. ## B. Macro & Client Decision Dynamics * **C. S. Decision-Making Slowed:** **Macro uncertainty** is causing delayed or prolonged client decisions—particularly in the U.S.—though pipeline conversions remain intact. ## C. Oracle Business Trends * **Regional Softness in Europe:** **Weakness in Oracle-related demand** observed in the U.K. and EU, though sustainability of the trend remains unclear. * **Resilient Sector Demand:** Oracle business remains project-driven with **strong traction in local government and higher education**, underpinned by a solid partnership with Oracle. * **New Leadership Confidence:** **Oracle Europe has a new leader with direct Oracle experience**, and management expresses confidence in the region’s strategic execution under his leadership. --- # 7. Guidance & Outlook ## A. Key Figures * **North America Run Rate Target:** **$30 Mn** (target) · **$28 Mn** (current investment) * **North America EBITDA Target:** **$3–4 Mn** growth expected at scale · **mid- to high-single-digit or double-digit EBIT margins** targeted ## B. North America Target * **Strategic Investment Phase:** North America in high-growth investment mode with elevated S&M spend, positioning for **disproportionate future returns** as scale inflection approaches. * **Path to Profitability:** Focus on profitable growth despite near-term margin pressure, with operational efficiencies underway to support margin expansion at scale. ## C. H2 Recovery Expectation * **AI-Driven Inflection Ahead:** Anticipating AI-led demonstrable growth in North America, with **significant uplift** expected in coming periods as client spending aligns with Mastek’s delivery strengths. * **Resilient Outlook Amid Macro Noise:** Despite a onetime revenue dip and global uncertainties, company maintains strong bottom-line resilience and expects a **positive H2 recovery**. * **Long-Term Strategic Edge:** Growing AI adoption favors infrastructure-capable partners; Oracle alliance positions Mastek for **disproportionate growth** despite no near-term revenue impact.